High-content micronucleus assay in genotoxicity profiling: initial-stage development and some applications in the investigative/lead-finding studies in drug discovery

Toxicological Sciences : an Official Journal of the Society of Toxicology
Madhu S MondalPhilip Bentley

Abstract

This article describes the first step toward full (that includes conditions for both absence and presence of metabolic activation) validation and drug discovery application of a 96-well, automated, high-content micronucleus (HCMN) assay. The current validation tests were performed using Chinese hamster ovary cells, in the absence of metabolic activation, against three distinct sets of drug-like compounds that represent all stages of a drug discovery pipeline. A compound categorization scheme was created based on quantitative relationships between micronucleus (MN) signals, cytotoxicity, and compound solubility. Results from initial validation compounds (n = 38) set the stage for differentiating overall positive and negative MN inducers. To delve deeper into the compound categorization process, a more extensive validation set, consisting of a larger set (n = 370) of "drug-like but less optimized" early-stage compounds, was used for further refinement of positive and negative compound categories. The predictivity and applicability of the assay for clinical stage compounds was ascertained using (n = 168) clinically developed marketed drugs or well-studied compounds. Upon full validation, a detailed analysis of results established ...Continue Reading

References

Dec 1, 1994·Cell Biology and Toxicology·W Frieauff, F Romagna
Jun 1, 1993·Patient Education and Counseling·J M McGinnis
Jul 10, 1996·Mutation Research·N F Cariello, W W Piegorsch
May 29, 1998·Mutation Research·W FrieauffW Suter
Jul 3, 1999·Mutagenesis·F Nesslany, D Marzin
Mar 29, 2000·Environmental and Molecular Mutagenesis·R R TiceY F Sasaki
May 10, 2001·Mutation Research·R D Snyder, J W Green
Oct 11, 2003·Mutation Research·Micheline Kirsch-VoldersAkihiro Wakata
Jul 4, 2006·Current Opinion in Chemical Biology·Willi Suter
Nov 28, 2006·Mutation Research·V ThybaudUNKNOWN Expert Working Group on Hazard Identification and Risk Assessment in Relation to In Vitro Testing
Dec 19, 2006·Toxicology and Applied Pharmacology·Feng CaoWilliam Kaufmann
Apr 21, 2007·Mutation Research·Dolores DiazChester Costales
Jul 10, 2008·Expert Opinion on Drug Metabolism & Toxicology·Richard M Walmsley
Oct 11, 2008·Mutation Research·Giovanni Brambilla, Antonietta Martelli
Nov 11, 2008·Current Drug Metabolism·L L Custer, K S Sweder

❮ Previous
Next ❯

Citations

Apr 4, 2012·Expert Opinion on Drug Discovery·Craig E Thomas, Yvonne Will
Aug 12, 2014·Environmental and Molecular Mutagenesis·Annemette V ThougaardJorrit J Hornberg
Apr 12, 2014·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Jasminka MrdjanovićVladimir Jurišić
Jun 9, 2016·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Andrew R CollinsMaria Dusinska
Oct 22, 2016·Chemical Research in Toxicology·Mikael Persson, Jorrit J Hornberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.